TRECO DOUGLAS A sold 26.7% of their position (7.52K shares) of INOZYME PHARMA, INC. on the open market
Open‑market sale worth $52.2K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/3/2024ACC: 0000950170-24-041301
-7.52K
Net shares
Net seller
$52.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
25K acquired · 32.52K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+25K
Price / share
—
Trade value
—
% of position
784.2%
4/1/2024
3.19K→28.19K
Common Stock
Direct
Shares
−7.52K
Price / share
$6.94
Trade value
$52.21K
% of position
26.7%
4/2/2024
28.19K→20.66K
Total
Net shares
+17.48K
Net value
-$52.21K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2024 | M · Option Exercise | +25K | — | — | 784.2% | 3.19K | 28.19K |
| Common Stock Direct | 4/2/2024 | S · Sale | −7.52K | $6.94 | $52.21K | 26.7% | 28.19K | 20.66K |
| Total | +17.48K | -$52.21K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
25K shares
Shares
−25K
Strike price
Held after
75K
Exercisable
—
4/1/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock25K shares | 4/1/2024 | M · Option Exercise | −25K | — | 75K |